Archives in Cancer Research

Case Report: Arch Cancer Res (6)

Need For HBV Cure: Persistent Risk For Subsequent New And Recurrent HCC Even After A Decade Of Successful Anti-HBV Therapy And Initial Tumor Ablation

Author(s): Brianna Shinn, Charles Kistler, Christopher Roth and Hie Won Hann*

DOI: 10.21767/2254-6081.100172

Abstract | Full-Text | PDF

Case Report: Arch Can Res (7)

Occurrence of Cerebellar Haemangioblastoma in a 13-Year-Old Girl with Neurofibromatosis Type 2: Report of a Case and Discussion of the Literature

Author(s): John Ouma*,Dereje Mamo and Marcus Gritzman

DOI: 10.21767/2254-6081.100173

Abstract | Full-Text | PDF

Research Article: Arch Can Res (8)

Biochemical Meaning of Defective Immune: Surveillance in Cancer Patients

Author(s): Tsuneo Kobayashi*

DOI: 10.21767/2254-6081.100174

Abstract | Full-Text | PDF

Case Report: Arch Can Res (9)

A Rare Case of Submandibular Gland Metastasis as the First Sign of Adenocarcinoma of the Lung

Author(s): Aarab Jihan*,Moukasse Yasmina, Sfaoua Hasnae, Allam Asma, Lahlali Fatima Zahra, El-Majjaoui Sanae, Kebdani Tayeb, El-Kacemi Hanan and Benjaafar Noureddine

DOI: 10.21767/2254-6081.100175

Abstract | Full-Text | PDF

Research Article: Arch Can Res (10)

Ultraviolet-Induced DNA Damage Promotes Methylation of the Cell-Cycle Checkpoint Kinase CHK1

Author(s): B Sharan Sharma

DOI: 10.21767/2254-6081.100176

Abstract | Full-Text | PDF

Research Article: Arch Can Res (11)

Non-methylated MGMT as Predictive Factor in Newly Diagnosed Glioblastoma Multiforme Treated with Bevacizumab Concurrent with Radiotherapy Followed by Adjuvant Bevacizumab plus Irinotecan versus Temozolomide Concurrent with Radiotherapy Followed by Adjuvant Temozolomide

Author(s): Lamiss Mohamed AE*, Asama Mohamed Elkady, Mamoun Abo Shosha and Dareen Mohamed

DOI: 10.21767/2254-6081.100177

Abstract | Full-Text | PDF